PerkinElmer to Acquire In-Vitro Diagnostics Company
Endocrinology testing specialist expands PerkinElmer’s immunodiagnostics segment
19-May-2021 -
PerkinElmer, Inc. and Immunodiagnostic Systems Holdings PLC (IDS) announced that they have reached an agreement on the terms of a recommended all cash offer whereby PerkinElmer will acquire IDS for approximately $155 million (£110 Million). The transaction has a total enterprise value of ...
acquisitions
in-vitro diagnostics
PerkinElmer